• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Pharyngeal Neoplasms

Pharyngeal Neoplasms - 58 Studies Found

Completed : Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
: Nasopharyngeal Neoplasms
: 2008-02-25
: Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen
Completed : Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
: Nasopharyngeal Neoplasms
: 2008-09-04
: Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni
Recruiting : Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
:
: 2025-08-02
Completed : The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
: Nasopharyngeal Neoplasms
: 2013-02-21
:
  • Drug: Cisplatin induction: Cis

Completed : Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
: Nasopharyngeal Neoplasms
: 2007-12-18
:
  • Procedure: Conventional Radiotherapy
  • Proce

Completed : Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
: Nasopharyngeal Neoplasms
: 2007-02-16
:
  • Drug: Gemcitabine 1000mg/m

Completed : Taxotere + Cisplatin in Nasopharyngeal Carcinoma
: Nasopharyngeal Neoplasms
: 2007-02-16
:
  • Drug: Docetaxel 75 mg/m²

Completed : Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
: Nasopharyngeal Neoplasms
: 2006-08-11
: Drug: Oxaliplatin 130mg/m² infusion day 1, repeat every 21 days
Active, not recruiting : Intensity Modulated Radiation Therapy for Head and Neck Cancer
: Nasopharyngeal Neoplasms
: 2005-09-12
:
  • Procedure: intensity modulated radiation therapy

Completed : Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function
: Nasopharyngeal Neoplasms
: 2005-07-22
: Procedure: Intensity-modulated radiation therapy
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.